Ipsen completes purchase of Apokyn,
Ipsen today announced that, following shareholder approval of Vernalis plc, Ipsen has completed its purchase of Apokyn ® and Vernalis' US Commercial Operations.
Aplitec, an IT firm, will return to the JSE through its parent company, Nasdaq-listed Net1 UEPS Technologies in an inward listing.